119 related articles for article (PubMed ID: 4949366)
1. Host factors in human malignant melanoma.
Lewis MG
Pathol Annu; 1971; 6():171-95. PubMed ID: 4949366
[No Abstract] [Full Text] [Related]
2. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
3. Microcytotoxicity and serum blocking factors in malignant melanoma and halo nevus.
Roenigk HH; Deodhar SD; Krebs JA; Barna B
Arch Dermatol; 1975 Jun; 111(6):720-5. PubMed ID: 1094959
[TBL] [Abstract][Full Text] [Related]
4. Immunological aspects of malignant melanoma of the choroid.
Rahi AH
Trans Ophthalmol Soc U K (1962); 1973; 93(0):79-91. PubMed ID: 4602170
[No Abstract] [Full Text] [Related]
5. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma.
Oettgen HF; Aoki T; Old LJ; Boyse EA; de Harven E; Mills GM
J Natl Cancer Inst; 1968 Oct; 41(4):827-43. PubMed ID: 4879578
[No Abstract] [Full Text] [Related]
6. [Immunology of malignant melanoma].
Bourgoin JJ
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):789-807. PubMed ID: 4559237
[No Abstract] [Full Text] [Related]
7. Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.
Currie GA
Proc R Soc Med; 1972 Feb; 65(2):144-7. PubMed ID: 4563684
[No Abstract] [Full Text] [Related]
8. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
9. Immunology and the melanomas.
Lewis MG
Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
[No Abstract] [Full Text] [Related]
10. Immunotherapy of malignant melanoma with vaccinia virus.
Roenigk HH; Deodhar S; St Jacques R; Burdick K
Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
[No Abstract] [Full Text] [Related]
11. The prevalence of melanocytic nevi on the soles in the Japanese population.
Kogushi-Nishi H; Kawasaki J; Kageshita T; Ishihara T; Ihn H
J Am Acad Dermatol; 2009 May; 60(5):767-71. PubMed ID: 19389519
[TBL] [Abstract][Full Text] [Related]
12. [Immune reactions against human malignant tumors].
Kåresen R
Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2555-60. PubMed ID: 4109664
[No Abstract] [Full Text] [Related]
13. Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan.
Kukita A; Ishihara K
J Invest Dermatol; 1989 May; 92(5 Suppl):210S-213S. PubMed ID: 2715652
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies with human neoplasms.
Morton DL
J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
[No Abstract] [Full Text] [Related]
15. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
Cohen AM; Millar RC; Ketcham AS
Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
[No Abstract] [Full Text] [Related]
16. Anti-tumour auto-antibody in human malignant melanoma.
Mansell PW; Verrier-Jones J
J Pathol; 1971 Feb; 103(2):Pxv. PubMed ID: 4936065
[No Abstract] [Full Text] [Related]
17. Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy.
Naldi L; Randi G; Di Landro A; La Vecchia C
Arch Dermatol; 2006 Jul; 142(7):935-6. PubMed ID: 16847220
[No Abstract] [Full Text] [Related]
18. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
Currie GA; Lejeune F; Fairley GH
Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
[TBL] [Abstract][Full Text] [Related]
19. [The immunology of malignant melanoma (author's transl)].
Schieferstein G
Klin Wochenschr; 1978 Mar; 53(16):241-53. PubMed ID: 355711
[No Abstract] [Full Text] [Related]
20. Autoimmune reactions in uveal melanoma.
Rahi AH
Br J Ophthalmol; 1971 Dec; 55(12):793-807. PubMed ID: 4946074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
